Baker Bros. Advisors »

Avalyn Pharma shares owned by Baker Bros. Advisors

Quarter-by-quarter ownership of Avalyn Pharma shares owned by Baker Bros. Advisors from 13F filings

Historical chart of Baker Bros. Advisors investment in Avalyn Pharma

Tip: Access up to 7 years of quarterly data

All positions including Avalyn Pharma held by Baker Bros. Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalyn Pharma by Baker Bros. Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $12M 350k 32.92

More positions owned by Baker Bros. Advisors

Incyte Corporation (INCY)
BeOne Medicines Sponsored Ads (ONC)
Revolution Medicines (RVMD)
Madrigal Pharmaceuticals (MDGL)
ACADIA Pharmaceuticals (ACAD)
Kymera Therapeutics (KYMR)
Insmed Incorporated Com Par $.01 (INSM)
Celcuity (CELC)
Kodiak Sciences (KOD)
Rhythm Pharmaceuticals (RYTM)
Praxis Precision Medicines I (PRAX)
Alkermes SHS (ALKS)
Summit Therapeutics (SMMT)
Grail (GRAL)
Abcellera Biologics (ABCL)

View all positions for Baker Bros. Advisors

Top funds holding Avalyn Pharma

Novo A/S
Sr One Capital Management
Perceptive Advisors
NVP Associates
Pivotal bioVenture Partners Investment Advisor
Citadel Advisors
Braidwell
Vanguard Capital Management
Soleus Capital Management
Infinitum Asset Management
Baker Bros. Advisors
Goldman Sachs Group
Federated Investors
ADAR1 Capital Management
Vanguard Portfolio Management

View all funds holding Avalyn Pharma